BARD DIAGNOSTIC SCIENCES INC has a total of 14 patent applications. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets measurement, biotechnology and machines are ABBOTT JAPAN CO LTD, LOCUS GENEX OY and MEIKANG BIO TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Unspecified technologies | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hass G Michael | 8 |
#2 | Kinders Robert J | 8 |
#3 | Enfield David L | 8 |
#4 | Van Aken Morgan | 5 |
#5 | Jones Tobin K | 3 |
#6 | Houghton Raymond L | 3 |
#7 | Paskell Stefan L | 2 |
#8 | Aken Morgan Van | 1 |
Publication | Filing date | Title |
---|---|---|
AU6451998A | Screening and treatment using complement regulator or receptor proteins | |
US6221621B1 | Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated | |
AU2660897A | Methods and compositions for screening for or modulating a tumor associated antigen | |
US6017703A | Methods and compositions for screening for or modulating a tumor associated antigen | |
US5541076A | Methods for determining the invasiveness of a bladder tumor | |
EP0710362A1 | Methods for determining the invasiveness of a bladder tumor | |
AU3321393A | Agglutination assays and kits employing colloidal dyes | |
EP0664453A1 | Detection of basement membrane components as diagnostic of cancer and other diseases |